- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
DRI Conducts Search at Cipla's Vikhroli Office, Bhiwandi Depot Over Imported Drug

Mumbai: The Directorate of Revenue Intelligence (DRI), Mumbai Zonal Unit, conducted search proceedings at the office of Cipla Limited in Vikhroli, Mumbai, and its depot in Bhiwandi, Thane, Maharashtra, in connection with the classification and exemption of an imported pharmaceutical finished product.
According to a regulatory disclosure, the search proceedings were initiated by the DRI on November 16,2026, under Section 105 of the Customs Act,1962.
The search was conducted at two company locations,including Cipla’s office in Vikhroli, Mumbai, and its depot situated in Bhiwandi, Thane. The company stated that it extended full cooperation and assistance to the authorities during the proceedings.
As detailed in the regulatory filing, the matter relates to the classification and exemption of an imported pharmaceutical finished product. The disclosure identifies the Directorate of Revenue Intelligence, Mumbai Zonal Unit, as the authority involved in the proceedings.
The search proceedings were initiated and concluded on the same day, November 16,2026. The company has clarified that the action has no material impact on its financials, operations or other activities.
Cipla Limited is a Mumbai-headquartered pharmaceutical company engaged in the development, manufacturing and marketing of pharmaceutical products. The company operates across multiple therapeutic segments and has a presence in domestic and international pharmaceutical markets.
The regulatory disclosure does not specify the name of the imported pharmaceutical product or provide further details regarding the classification or exemption issue under examination.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

